Improving Tobacco Treatment Rates for Cancer Patients Who Smoke

NACompletedINTERVENTIONAL
Enrollment

685

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

January 24, 2024

Conditions
CancerTobacco UseSmokingNicotine Dependence
Interventions
OTHER

Tobacco Use Treatment Service and Varenicline Management

The VM intervention builds upon the established TUT Service process. In addition to connecting the patient to TUT Service via electronic referral, it activates a medication management protocol that: 1) actively confirms no evidence of renal failure or pregnancy with oncology provider, 2) automates a referral to prescribing providers within the TUT Service team, prompting a call-back to patient within 24 hours, 3) provides written AVS instructions to contact TUT Service for initiation instructions and clinic appointment, and 4) pends a varenicline prescription to the medication list, ready for reconciliation by TUT Service prescribing clinicians. The protocol formalizes standard management principles for varenicline, including follow-up evaluation, pre-quit period duration, and side effect amelioration.

Trial Locations (2)

19104

Penn Presbyterian Medical Center, Philadelphia

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER